Insecticides India FY26 revenue rises 7% to ₹2,140 crore
Insecticides (India) Limited reported a 7% rise in FY26 revenue to ₹2,140 crore, while net profit declined 2% to ₹139 crore. Q4 revenue grew 19% to ₹426 crore. The Board approved audited financial results, an Employee Stock Purchase Scheme, and key management appointments.

*this image is generated using AI for illustrative purposes only.
Insecticides (India) Limited reported a 7% increase in revenue from operations to ₹2,140 crore for the financial year ended March 31, 2026, compared to ₹2,000 crore in FY25. Net profit for the year declined 2% to ₹139 crore from ₹142 crore in the previous year. The company attributed the performance to healthy growth momentum and stable margins despite a challenging operating environment marked by erratic rainfall and global disruptions.
Consolidated Financial Performance
For the quarter ended March 31, 2026, revenue grew 19% to ₹426 crore from ₹359 crore in Q4 FY25. Net profit for the quarter stood at ₹12 crore, compared to ₹14 crore in the same period last year. EBITDA for the full year rose 3% to ₹227 crore, while EBITDA margins stood at 10.6%. Earnings per share (EPS) for the full year was ₹47.91, compared to ₹48.38 in the previous year.
The following table summarises the company's financial performance:
| Particulars (₹ In Crs) | Year Ended 31-03-2026 | Year Ended 31-03-2025 | Y-o-Y |
|---|---|---|---|
| Revenue from Operations | 2,140 | 2,000 | 7% |
| Total Income | 2,151.72 | 2,006.95 | |
| Profit for the Year | 139 | 142 | -2% |
| Earnings Per Share (Basic) | 47.91 | 48.38 |
Operational Highlights
The company recorded a total turnover of ₹2,140 crore for FY26. Premium products delivered robust growth of 24% during Q4FY26. Key brands including Torry Super, Shinwa, Centran, Sparcle, and Kunoichi witnessed strong market traction. The company strengthened its collaboration with Corteva Agriscience through the launch of GRANUVIA in May 2026. It introduced five new launches in FY26, adding more than 25 products in the last three years.
Capital Efficiency and Assets
As of March 31, 2026, net working capital stood at ₹827.92 crore. Inventory days improved to 194 days from 238 days in the previous year. Trade receivables days increased to 83 days from 70 days, while trade payables days decreased to 109 days from 136 days. Total assets for the year stood at ₹2,000.18 crore, with total equity and liabilities at ₹2,000.18 crore.
Board Approvals and Appointments
The Board of Directors approved the audited financial results for the quarter and year ended March 31, 2026, based on the unmodified opinion of Joint Statutory Auditors M/s S S Kothari Mehta & Co., LLP and M/s Devesh Parekh & Co. The Board approved the formulation of the Employee Stock Purchase Scheme 2026, covering up to 2,00,000 equity shares, subject to shareholder approval. Mrs. Nikunj Aggarwal resigned as Whole Time Director with immediate effect. The Board appointed Mr. Sanskar Aggarwal as Whole Time Director (Additional) for a term of five years effective May 28, 2026, subject to shareholder approval. Mr. Atul Kumar was appointed as Vice President- Sales (North). M/s T Jain & Associates were appointed as Internal Auditor for a period of five years effective April 01, 2026.
Historical Stock Returns for Insecticides
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -3.86% | -1.42% | +5.64% | +1.27% | -9.98% | +106.50% |
How will the company address the widening trade receivables days to ensure cash flow stability?
What is the expected revenue contribution from the newly launched GRANUVIA product in the coming fiscal year?
Will the increase in trade payables days impact supplier relationships or input costs in FY27?


































